← Leaderboards
Pamela L. Lutsey
University Of Minnesota
$7,472,225
Attributed
$7,912,561
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,912,561 · 7
By mechanism
R01$4,221,158 · 2
U01$1,580,230 · 1
T32$880,673 · 1
K24$520,768 · 1
N01$489,484 · 1
R21$220,248 · 1
Top collaborators
- James S Pankow2 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Alvaro Alonso$12,399,860
- Rui Zhang$7,242,092
- Joseph Mark Metzger$31,677,280
- Ken M. Kunisaki$6,591,253
- David Walk$7,834,265
Others in their field
Top investigators on “Participant”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$407,724,307
- Lawrence Corey · Fred Hutchinson Cancer Center$333,313,234
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Albert Lazzarini · California Institute Of Technology$300,431,866
Research focus
ParticipantCohortProspectiveCardiovascular DiseasesRaceSamplingCharacteristicsHypertensionAtrial FibrillationCardiovascular Disorder RiskDisease OutcomeCardiovascular SystemPharmaceutical PreparationsPrevalencePreventionAdverse OutcomeDrug InteractionsEffectivenessGuidelinesCommunitiesOralComparative EffectivenessAnticoagulantsElderly
Grant awards (21)
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER, TASK AREA B$489,484
N01 · FY2025 · HL · contact PI
Cardiovascular Disease Epidemiology & Prevention$374,144
T32 · FY2025 · HL
Mentoring and Research in Patient-Oriented Cardiovascular Pharmacoepidemiology$104,156
K24 · FY2025 · HL · contact PI
Cardiovascular Disease Epidemiology & Prevention$506,529
T32 · FY2024 · HL
Mentoring and Research in Patient-Oriented Cardiovascular Pharmacoepidemiology$104,141
K24 · FY2024 · HL · contact PI
Mentoring and Research in Patient-Oriented Cardiovascular Pharmacoepidemiology$104,156
K24 · FY2023 · HL · contact PI
Mentoring and Research in Patient-Oriented Cardiovascular Pharmacoepidemiology$104,135
K24 · FY2022 · HL · contact PI
Mentoring and Research in Patient-Oriented Cardiovascular Pharmacoepidemiology$104,180
K24 · FY2021 · HL · contact PI
Contemporary Venous Thromboembolism Treatment$428,815
R01 · FY2020 · HL · contact PI
Contemporary Venous Thromboembolism Treatment$419,575
R01 · FY2019 · HL · contact PI
ARIC Neurocognitive Study (ARIC-NCS)$638,149
U01 · FY2018 · HL · contact PI
Contemporary Venous Thromboembolism Treatment$444,447
R01 · FY2018 · HL · contact PI
ARIC Neurocognitive Study (ARIC-NCS)$942,081
U01 · FY2017 · HL · contact PI
Contemporary Venous Thromboembolism Treatment$650,269
R01 · FY2017 · HL · contact PI
Serum Vitamin D and Cardiovascular Disease Risk in the Biethnic ARIC Cohort$350,226
R01 · FY2014 · HL · contact PI
Sleep Disordered Breathing and Incident Cognitive Decline and Dementia: ARIC$111,720
R21 · FY2014 · HL · contact PI
Serum Vitamin D and Cardiovascular Disease Risk in the Biethnic ARIC Cohort$335,881
R01 · FY2013 · HL · contact PI
Sleep Disordered Breathing and Incident Cognitive Decline and Dementia: ARIC$108,528
R21 · FY2013 · HL · contact PI
Serum Vitamin D and Cardiovascular Disease Risk in the Biethnic ARIC Cohort$768,891
R01 · FY2012 · HL · contact PI
Serum Vitamin D and Cardiovascular Disease Risk in the Biethnic ARIC Cohort$96,130
R01 · FY2012 · HL · contact PI
Serum Vitamin D and Cardiovascular Disease Risk in the Biethnic ARIC Cohort$726,924
R01 · FY2011 · HL · contact PI